Try our Chrome extension
Easily add the current web-page from your browser directly into your changedetection.io tool, more great features coming soon!
Chrome Webstore
Changedetection.io needs your support!
You can help us by supporting changedetection.io on these platforms;
- Rate us at AlternativeTo.net
- Star us on GitHub
- Follow us at Twitter/X
- Check us out on LinkedIn
- And tell your friends and colleagues :)
The more popular changedetection.io is, the more time we can dedicate to adding amazing features!
Many thanks :)
changedetection.io team
Not yet seconds ago
False
Not yet seconds ago
2 months ago
Pro-tip: Highlight text to add to ignore filters
* Home
* About
* Portfolio
* Meet the Team
* News
* Contact
* Investor Portal
* info@chv.vc
* 129 South Street, 4th Floor, Boston, MA 02111
*
Home / News
News & Updates
Featured Story
Esperto Medical Announces Completion of Oversubscribed Series A Financing
* February 18, 2025
* -
* Esperto
Sera Prognostics Announces Pricing of $50 Million Public Offering
* February 14, 2025
* -
* Sera Prognostics
Select a Company Allegro Diagnostics (1) Aria CV (5) AtaCor Medical (4) Augmenix (1) Biocius (1) BioTrove (1) Conformal (14) GI Dynamics (1) Sera Prognostics (29) nVision (1) Maxwell Health (1) Vortex Medical (1) Novazyme Pharmaceuticals (1) Saphena Medical (3) Brixton Biosciences (2) PanTher Therapeutics (6) Instylla Inc. (3) Catalyst Health Ventures (2) Epitel (5) Avive (2) Rejoni (1) Venova (1) Esperto (1)
The Latest
Esperto Medical Announces Completion of Oversubscribed Series A Financing
* February 18, 2025
* -
* Esperto
Sera Prognostics Announces Pricing of $50 Million Public Offering
* February 14, 2025
* -
* Sera Prognostics
Steve Pacelli Appointed CEO of Epitel, Inc.
* February 13, 2025
* -
* Epitel
Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting
* December 9, 2024
* -
* Sera Prognostics
Conformal Medical Announces Launch of the GLACE Study with Next-Gen CLAAS® AcuFORM™ Left Atrial Appendage Occlusion Device
* October 2, 2024
* -
* Conformal
Venova Medical Announces $30 Million Series B Financing and Appointment of New Board Member
* September 4, 2024
* -
* Venova
PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment of Pancreatic Cancer
* August 13, 2024
* -
* PanTher Therapeutics
Sera Prognostics Added to Russell 2000 and 3000 Indexes Following Conclusion of 2024 Indexes Annual Reconstitution
* July 1, 2024
* -
* Sera Prognostics
Show More
Let’s Connect.
Contact Us
Sitemap
* Home
* About
* Portfolio
* Meet the Team
* News
* Contact
* Investor Portal
About
Catalyst Health Ventures (CHV) is a venture capital fund investing in transformative medical technologies addressing global unmet needs.
Contact
* info@chv.vc
Boston Web Design by GoingClear
|
For now, Differences are performed on text, not graphically, only the latest screenshot is available.
Screenshot requires Playwright/WebDriver enabled